231 related articles for article (PubMed ID: 12516984)
1. Analysis of uncertainty in health care cost-effectiveness studies: an introduction to statistical issues and methods.
O'Brien BJ; Briggs AH
Stat Methods Med Res; 2002 Dec; 11(6):455-68. PubMed ID: 12516984
[TBL] [Abstract][Full Text] [Related]
2. Representing uncertainty: the role of cost-effectiveness acceptability curves.
Fenwick E; Claxton K; Sculpher M
Health Econ; 2001 Dec; 10(8):779-87. PubMed ID: 11747057
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness acceptability curves--caveats quantified.
Jakubczyk M; Kamiński B
Health Econ; 2010 Aug; 19(8):955-63. PubMed ID: 19688780
[TBL] [Abstract][Full Text] [Related]
4. Trying to do better than average: a commentary on 'statistical inference for cost-effectiveness ratios'.
Briggs A; Fenn P
Health Econ; 1997; 6(5):491-5. PubMed ID: 9353649
[TBL] [Abstract][Full Text] [Related]
5. Fieller's method and net health benefits.
Heitjan DF
Health Econ; 2000 Jun; 9(4):327-35. PubMed ID: 10862076
[TBL] [Abstract][Full Text] [Related]
6. Affordability and cost-effectiveness: decision-making on the cost-effectiveness plane.
Sendi PP; Briggs AH
Health Econ; 2001 Oct; 10(7):675-80. PubMed ID: 11747050
[TBL] [Abstract][Full Text] [Related]
7. Something old, something new, something borrowed, something blue: a framework for the marriage of health econometrics and cost-effectiveness analysis.
Hoch JS; Briggs AH; Willan AR
Health Econ; 2002 Jul; 11(5):415-30. PubMed ID: 12112491
[TBL] [Abstract][Full Text] [Related]
8. Bayesian methods for design and analysis of cost-effectiveness trials in the evaluation of health care technologies.
O'Hagan A; Stevens JW
Stat Methods Med Res; 2002 Dec; 11(6):469-90. PubMed ID: 12516985
[TBL] [Abstract][Full Text] [Related]
9. Confidence intervals for cost-effectiveness ratios: an application of Fieller's theorem.
Willan AR; O'Brien BJ
Health Econ; 1996; 5(4):297-305. PubMed ID: 8880166
[TBL] [Abstract][Full Text] [Related]
10. Expected value of information and decision making in HTA.
Eckermann S; Willan AR
Health Econ; 2007 Feb; 16(2):195-209. PubMed ID: 16981193
[TBL] [Abstract][Full Text] [Related]
11. "Time Traveling Is Just Too Dangerous" but Some Methods Are Worth Revisiting: The Advantages of Expected Loss Curves Over Cost-Effectiveness Acceptability Curves and Frontier.
Alarid-Escudero F; Enns EA; Kuntz KM; Michaud TL; Jalal H
Value Health; 2019 May; 22(5):611-618. PubMed ID: 31104743
[TBL] [Abstract][Full Text] [Related]
12. The usefulness of average cost-effective ratios.
Laska EM; Meisner M; Siegel C
Health Econ; 1997; 6(5):497-504. PubMed ID: 9353650
[TBL] [Abstract][Full Text] [Related]
13. A Bayesian approach to stochastic cost-effectiveness analysis.
Briggs AH
Health Econ; 1999 May; 8(3):257-61. PubMed ID: 10348420
[TBL] [Abstract][Full Text] [Related]
14. The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies.
Claxton K
J Health Econ; 1999 Jun; 18(3):341-64. PubMed ID: 10537899
[TBL] [Abstract][Full Text] [Related]
15. Estimating country-specific cost-effectiveness from multinational clinical trials.
Willke RJ; Glick HA; Polsky D; Schulman K
Health Econ; 1998 Sep; 7(6):481-93. PubMed ID: 9809707
[TBL] [Abstract][Full Text] [Related]
16. Limitations of acceptability curves for presenting uncertainty in cost-effectiveness analysis.
Groot Koerkamp B; Hunink MG; Stijnen T; Hammitt JK; Kuntz KM; Weinstein MC
Med Decis Making; 2007; 27(2):101-11. PubMed ID: 17409361
[TBL] [Abstract][Full Text] [Related]
17. A preliminary model-based assessment of the cost-utility of a screening programme for early age-related macular degeneration.
Karnon J; Czoski-Murray C; Smith K; Brand C; Chakravarthy U; Davis S; Bansback N; Beverley C; Bird A; Harding S; Chisholm I; Yang YC
Health Technol Assess; 2008 Jun; 12(27):iii-iv, ix-124. PubMed ID: 18513468
[TBL] [Abstract][Full Text] [Related]
18. Uncertainty of incremental cost-effectiveness ratios. A comparison of Fieller and bootstrap confidence intervals.
Severens JL; De Boo TM; Konst EM
Int J Technol Assess Health Care; 1999; 15(3):608-14. PubMed ID: 10874387
[TBL] [Abstract][Full Text] [Related]
19. Sample size and power issues in estimating incremental cost-effectiveness ratios from clinical trials data.
Willan AR; O'Brien BJ
Health Econ; 1999 May; 8(3):203-11. PubMed ID: 10348415
[TBL] [Abstract][Full Text] [Related]
20. Definition, interpretation and calculation of cost-effectiveness acceptability curves.
Löthgren M; Zethraeus N
Health Econ; 2000 Oct; 9(7):623-30. PubMed ID: 11103928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
